As a tumor suppressor, mutations and alterations in PPP2R1B have been found in human cancers, including colon cancer, lung cancer and cervical cancer, and is involved in chemotherapy sensitivity (Wang et al., 1998; Tamaki et al., 2004; Yeh et al., 2007). This evidence concerns the gene PPP2R1B and neoplasm.